GPO hearing rescheduled
This article was originally published in The Gray Sheet
Executive Summary
Senate Judiciary Committee/Antitrust, Competition Policy & Consumer Rights Subcommittee will host Sept. 14 hearing on "Hospital Group Purchasing: How to Maintain Innovation and Cost Savings." A discussion draft that would authorize annual HHS certification of GPO compliance with federal anti-competition regulations likely will be circulated at the hearing, previously scheduled for Sept. 8 (1"The Gray Sheet" Sept. 6, 2004, p. 25)...
You may also be interested in...
Senate Subcommittee To Deliberate GPO Legislation At Sept. 8 Hearing
Annual HHS certification of GPO compliance with federal anti-competition regulations would be authorized under a proposal being floated by the Senate Judiciary/Antitrust Subcommittee
Japan Regulatory Update: Revised Law Widens RWD Scope, Price Revisions/Listings
Japan now allows pseudonymized personal data for medical use under a licensing system for wider use of real-world data. Meanwhile, a national cost-effectiveness assessment scheme has slashed reimbursement prices for Lagevrio and Kerendia, and Alexion’s Voydeya has been added to the reimbursement tariff.
Abbott's ‘Bedrock Of Good Health’ Nutritionals Business Faces Mounting Infant Formula Litigation
Nutritional product business had 5.1% Q1 sales growth and is like Abbott’s other segments, “super well-aligned to the global demographics and trends in health care,” says CEO Ford. But as it defends complaints of damages from powder formulas made at facility found with unsafe levels of bacterial contaminants, Abbott’s also targeted in litigation alleging failure to warn about risk of infants born prematurely developing necrotizing enterocolitis if fed cow’s milk-based formula.